fr   en
Acquisitions
Select a company :
Choose date:
«      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10      »      
Date Acquiring pharma company Acquired biotech company Amount Terms / other
2009-03-03 Stemcells (USA) Stem Cell Sciences (UK) $ 4.85 million See details
2009-03-03 Pharmexa (Danemark) Affitech (Norway) The acquisition has been structured as a tender offer to Affitech shareholders that will be consummated by Pharmexa issuing of up to 133,861,922 new shares of each nominal DKK 0.5 (DKK 67 million - (€9 million) to the existing shareholders of Affitech for the entire share capital of Affitech.

- On March 27, 2009 Pharmexa announced that it has received confirmation of the approval of the transaction from more than 99,1 % of the shareholders in Affitech. Simultaneously, some Affitech shareholders have undertaken to invest a minimum of NOK 32.5 million (€3.6 million) in the enlarged company post-transaction.
See details
2008-12-22 Intercytex (UK) Axordia (UK) £1.68 million (€ 1.8 million) See details
2008-12-18 Wyeth Pharmaceuticals (USA) Thiakis Ltd (UK) $30 million. Additional payments of up to approximately $120 million would be payable under achievement of some development milestones. See details
2008-11-27 Biomonitor (Denmark) Neutekbio (Ireland) Financial details were not disclosed. See details
2008-11-25 Roche (Switzerland) Memory Pharmaceuticals (USA) $50 million (€39.5 million) See details
2008-11-11 Zydus Cadila (India) Etna Biotech, italian subsidiary of Crucell (The Netherlands) Financial details were not disclosed. See details
2008-11-05 Chemventures Pty (Australia) BioFocus DPI chemistry facility in San Diego Financial details were not disclosed. See details
2008-10-29 GSK (UK) Genelabs Technologies (USA) $57 million (£35 million) See details
2008-10-24 Biotie Therapies (Finland) elbion GmbH (Germany) Financial details were not disclosed. See details
2008-10-21 Novartis (Switzerland) Nektar Therapeutics (USA) $ 115 million (€ 91.6 million) See details
2008-09-25 Sanofi Pasteur Holding/Sanofi Pasteur (France) Acambis (UK) £285 million (€ 358.8 million) See details
2008-09-18 BTG plc (UK) Protherics (UK)   See details
2008-09-16 Bayer Healthcare (Germany) Direvo Biotech (Germany) € 210 million See details
2008-09-16 group of investors Direvo Industrial Biotechnology (Germany) undisclosed amount See details
«      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10      »